Search Results - Teale, C.W.

  • Showing 1 - 7 results of 7
Refine Results
  1. 1
    Does Personalised Health Care (PHC) in Oncology Require New Approaches to Clinical Development, Regulatory Assessment, and Economic Evaluation?

    Does Personalised Health Care (PHC) in Oncology Require New Approaches to Clinical Development, Regulatory Assessment, and Economic Evaluation? by Teale, C.W, Satherley, A.W, Maertens, P, Kreyenberg, K, Konieczny, A

    Published in Value in health
    Get full text
    Article
    Save to List
    Saved in:
  2. 2
    A Multi-Stakeholder (Physician, Payer, Patient, and Industry) Qualitative Analysis of the Policies That Would Support A Sustainable European Biosimilars Medicines Market Combined With A Quantitative Analysis of the Multi-Stakeholder Benefits A Sustainable Medicines Market Would Deliver

    A Multi-Stakeholder (Physician, Payer, Patient, and Industry) Qualitative Analysis of the Policies That Would Support A Sustainable European Biosimilars Medicines Market Combined W... by Whitehouse, J.T, Teale, C.W, Glover, J.C, Taylor, C, Lino, Mendonca V

    Published in Value in health
    Get full text
    Article
    Save to List
    Saved in:
  3. 3
    PHP317 - IDENTIFYING THE CHANGES REQUIRED IN HEALTH TECHNOLOGY ASSESSMENT SYSTEMS IF OUTCOMES ARE TO BE OPTIMIZED IN A DIGITAL WORLD WHERE PERSONALIZED DATA AND PRECISION MEDICINE COLLIDE

    PHP317 - IDENTIFYING THE CHANGES REQUIRED IN HEALTH TECHNOLOGY ASSESSMENT SYSTEMS IF OUTCOMES ARE TO BE OPTIMIZED IN A DIGITAL WORLD WHERE PERSONALIZED DATA AND PRECISION MEDICINE... by Teale, C.W., Khan, S., Heupel, M.

    Published in Value in health
    Get full text
    Article
    Save to List
    Saved in:
  4. 4
    PHP22 - IS THE EUROPEAN BIOSIMILAR MEDICINES MARKET BECOMING UNSUSTAINABLE? AN EXPLORATION OF THE COMBINED IMPACT OF COMPETITION, INTERCHANGEABILITY, PROCUREMENT, AND PRICING

    PHP22 - IS THE EUROPEAN BIOSIMILAR MEDICINES MARKET BECOMING UNSUSTAINABLE? AN EXPLORATION OF THE COMBINED IMPACT OF COMPETITION, INTERCHANGEABILITY, PROCUREMENT, AND PRICING by Teale, C.W., Sogokon, P., Panciera, D.

    Published in Value in health
    Get full text
    Article
    Save to List
    Saved in:
  5. 5
    PCP2 - IS DIGITAL TECHNOLOGY BRINGING THE ADOPTERS CLOSER TO THE DECISION-MAKERS: A COMPARATIVE ASSESSMENT ACROSS FIVE EUROPEAN MARKETS

    PCP2 - IS DIGITAL TECHNOLOGY BRINGING THE ADOPTERS CLOSER TO THE DECISION-MAKERS: A COMPARATIVE ASSESSMENT ACROSS FIVE EUROPEAN MARKETS by Khan, S., Teale, C.W., Heupel, M., Czira, A.

    Published in Value in health
    Get full text
    Article
    Save to List
    Saved in:
  6. 6
    PCN176 - Does Personalised Health Care (PHC) in Oncology Require New Approaches to Clinical Development, Regulatory Assessment, and Economic Evaluation?

    PCN176 - Does Personalised Health Care (PHC) in Oncology Require New Approaches to Clinical Development, Regulatory Assessment, and Economic Evaluation? by Teale, C.W., Satherley, A.W., Maertens, P., Kreyenberg, K., Konieczny, A.

    Published in Value in health
    Get full text
    Article
    Save to List
    Saved in:
  7. 7
    PHP28 - A Multi-Stakeholder (Physician, Payer, Patient, and Industry) Qualitative Analysis of the Policies That Would Support A Sustainable European Biosimilars Medicines Market Combined With A Quantitative Analysis of the Multi-Stakeholder Benefits A Sustainable Medicines Market Would Deliver

    PHP28 - A Multi-Stakeholder (Physician, Payer, Patient, and Industry) Qualitative Analysis of the Policies That Would Support A Sustainable European Biosimilars Medicines Market Co... by Whitehouse, J.T., Teale, C.W., Glover, J.C., Taylor, C., Lino, Mendonca V.

    Published in Value in health
    Get full text
    Article
    Save to List
    Saved in:

Search Tools: